Delivery Order SPE2DB22D3016-SPE2DB24FAUC6
- Not listed
- This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM9U2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,308.40, is for the delivery of Lidocaine 5% Patch 30S, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order, with a period of performance extending through March 10, 2025. Amerisourcebergen Drug Corp is the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,539.08 contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has an ultimate completion date of February 28, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award is for a delivery order with a firm fixed price of $1,168.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% Patch 30s, a medical product used for pain management. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
- This federal contract award, with ID SPE2DB20D1102|SPE2DB24FC5UY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,654.25, is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 24, 2023. The contract does not have a set-aside...
- This federal contract award, valued at $1,942.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has an ultimate completion date of April 2, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a...
- This federal contract award SPE2DB20D3304 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% patches. The $7,037 Firm Fixed Price contract has a completion date of December 11, 2024 and was awarded on December 10, 2024. This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This federal contract award, valued at $16,656.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has an ultimate completion date of April 9, 2025 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and was awarded through open competition. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.40 Firm Fixed Price delivery order contract covers the supply of Lidocaine 5% Patch 30S, a medical product used for pain management. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $2,159.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, which are used for pain management. It is a firm-fixed-price delivery order contract with a completion date of January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, identified as SPE2DB22D2005|SPE2DB25FJJL0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, with an ultimate completion date of March 10, 2025 and a ceiling value of $7,120.72. The contract is a Delivery Order and has a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAUC6Delivery Order
This federal contract award, with an identification number of SPE2DB22D3016|SPE2DB24FAUC6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,727.30, is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. This is a Firm Fixed Price Delivery Order contract with a completion date of May 2, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not have any identified major subcontractors. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/1/24 |